Future Perspectives in the Pharmacological Treatment of Atrial Fibrillation and Ventricular Arrhythmias in Heart Failure

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|21|8|1011-1029

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.21, Iss.8, 2015-03, pp. : 1011-1029

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacological Approaches in the Treatment of Atrial Fibrillation

By  

Current Medicinal Chemistry, Vol. 11, Iss. 1, 2004-01 ,pp. : 13-28

Bentham Science Publishers

Access to resources Recommend Favorite

Flecainide acetate for the treatment of atrial and ventricular arrhythmias

By Apostolakis Stavros   Oeff Michael   Tebbe Ulrich   Fabritz Larissa   Breithardt Günter   Kirchhof Paulus  

Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 3, 2013-02 ,pp. : 347-357

Informa Healthcare

Access to resources Recommend Favorite

Valsartan reduces risk of atrial fibrillation in heart failure

By  

Inpharma, Vol. 1, Iss. 1488, 2005-01 ,pp. : 17-17

Adis International

Access to resources Recommend Favorite

Assessment of Quality of Life in Pharmacological Treatment of Atrial Fibrillation

By  

Heart Drug, Vol. 3, Iss. 1, 2003-07 ,pp. : 14-24

Karger

Access to resources Recommend Favorite

The immediate future for the medical treatment of atrial fibrillation

By Pedersen Ole Dyg   Brendorp Bente   Køber Lars   Torp-Pedersen Christian  

Expert Opinion on Emerging Drugs, Vol. 7, Iss. 2, 2002-10 ,pp. : 259-268

Informa Healthcare

Access to resources Recommend Favorite